MaxCyte (MXCT) launches CHANGE-seq-BE and ONE-seq-BE off-target tools
MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ aimed at strengthening off-target assessment for genome editing therapies.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.